Revolutionary Bladder Cancer Device Shows 82% Success Rate: Hope for Thai Patients Facing Life-Altering Surgery
Breakthrough medical technology offers new hope for thousands of Thai patients who might otherwise lose their bladders to cancer, with promising results from international trials suggesting a paradigm shift in urological care.
In a development that could transform bladder cancer treatment across Thailand, researchers have unveiled remarkable results from the TAR-200 device, a groundbreaking intravesical drug-delivery system that eliminated visible cancer in approximately 82% of patients with high-risk non-muscle-invasive bladder cancer. These patients had previously failed standard BCG immunotherapy, leaving them with few alternatives beyond radical bladder removal surgery.